Hadassah

Stem Cells and Platelets: Hadassah Pioneers Stroke Strategy

Monday, Jul 27 2015

The research team in Hadassah’s Peritz and Chantal Scheinberg Cerebrovascular Research Laboratory

The Hadassah Medical Center’s pioneering researchers are leading the way in exploring a novel cutting-edge stem cell treatment to reverse the disability a stroke leaves in its wake.

While the brain contains stem cells that are capable of some regeneration, the problem is that there are not enough of them and they don’t survive for a long time. To be effective in alleviating the damage cause by stroke, these stem cells need to be enhanced. 

Working with an animal model, the research team in Hadassah’s Peritz and Chantal Scheinberg Cerebrovascular Research Laboratory discovered a powerful enhancer: platelets shed microparticles which contain crucial growth factors that will trigger development of new blood cells and nerve cells, as well as repair and protect existing ones. The researchers, under the direction of Prof. Ronen Leker, head of the Scheinberg Laboratory and Hadassah’s Stroke Service, injected platelets into the cerebral hemispheres of the animal brain, providing a “supportive niche” for the existing stem cells to proliferate. (The platelets were harvested from old donations to the blood bank that were going to be discarded due to expiration date; however, Prof. Leker explains, any platelets can be used.)

The result: The platelets significantly increased the proliferation of the neural stem cells and the growth of new blood vessels, Prof. Leker reports. In addition, the rats experienced a reduction in the stroke-induced behavioral deficits.

The next step is testing the treatment in human trials. Incidence of stroke is 775,000 individuals annually in the United States, 1,000,000 in Europe, and 15,000 in Israel. Hadassah’s physicians use the latest techniques to treat stroke when the patients arrive at the hospital in time--stentreivers, for example, which pull the clot out of the blood vessel, leaving no neurological deficits. But many patients arrive at the hospital too late for physicians to prevent neurological losses.

Most strokes, Prof. Leker reports, are ischemic, where a blood vessel either leading to the brain or in the brain is blocked. A person who suffers a stroke loses 1.9 million neurons every minute that a stroke is untreated, says Prof. Leker, and “so we say ‘Time is brain.’ ” About 15-30 percent of individuals who experience a stroke are permanently disabled; they are unable to walk, talk clearly or feed themselves. Finding a means to regenerate the damaged blood vessels and nerve cells could give a new lease on life to hundreds of thousands of people around the world.  

Comments

From: Camille on August 20, 2015
Could this treatment also help a person who has had a TBI and is left hemiplegic
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Jan 13 2017

Saving Children in the Nick of Time at Hadassah

When a four-year-old, blue and critically ill, was rushed into the pediatric emergency room at Hadassah Hospital Mount Scopus, Dr. David Rekhtman, head of the ER, and his team deciphered that the child had somehow consumed methadone.

READ MORE ›
alt_text

Friday, Jan 13 2017

Peace in Sight: An Israeli, Palestinian, and Hadassah Australia Collaboration

St. John of Jerusalem Eye Hospital, in collaboration with Hadassah Medical Center, has received a €500,000 grant from the European Union to establish a genetic research unit to serve the Palestinian communities.

READ MORE ›
alt_text

Friday, Jan 13 2017

A Second Chance at Life, Thanks to Hadassah’s Heart Institute

A resident of a rural settlement called Dishon, established by Libyan Jewish immigrants in 1953, Eyal Amar, age 47, was rather young to suffer a devastating heart attack. Nevertheless, he did, but thanks to the courage and skill of the specialists at the Hadassah Medical Organization’s Heart Institute and their complex protocol to redesign his heavily damaged heart, Eyal is able to walk and breathe again.

READ MORE ›
alt_text

Tuesday, Jan 10 2017

From Locked Jaw to Osteoarthritis: Hadassah Discovery Leads to New Treatment

What began as a solution to locked jaw--temporomandibular joint (TMJ) disorder--has led to the creation of a novel non-opioid pharmaceutical candidate for the treatment of osteoarthritis pain, thanks to a Hadassah Medical Organization discovery and collaboration with colleagues at the Hebrew University and the Technion.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More